SG47122A1 - Enantiomerically pure(-)-liarozole - Google Patents

Enantiomerically pure(-)-liarozole

Info

Publication number
SG47122A1
SG47122A1 SG1996009264A SG1996009264A SG47122A1 SG 47122 A1 SG47122 A1 SG 47122A1 SG 1996009264 A SG1996009264 A SG 1996009264A SG 1996009264 A SG1996009264 A SG 1996009264A SG 47122 A1 SG47122 A1 SG 47122A1
Authority
SG
Singapore
Prior art keywords
liarozole
enantiomerically pure
enantiomerically
pure
Prior art date
Application number
SG1996009264A
Inventor
Marc Gaston Venet
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SG47122A1 publication Critical patent/SG47122A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1996009264A 1994-02-18 1995-02-10 Enantiomerically pure(-)-liarozole SG47122A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94200418 1994-02-18

Publications (1)

Publication Number Publication Date
SG47122A1 true SG47122A1 (en) 1998-03-20

Family

ID=8216651

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996009264A SG47122A1 (en) 1994-02-18 1995-02-10 Enantiomerically pure(-)-liarozole

Country Status (11)

Country Link
EP (1) EP0745078A1 (en)
JP (1) JPH09508915A (en)
CN (1) CN1141041A (en)
AU (1) AU688852B2 (en)
IL (1) IL112689A0 (en)
MX (1) MX9603510A (en)
NZ (1) NZ279228A (en)
SG (1) SG47122A1 (en)
TW (1) TW418203B (en)
WO (1) WO1995022541A1 (en)
ZA (1) ZA951342B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1992228A1 (en) * 2007-05-14 2008-11-19 Bayer CropScience AG Insecticidal substituted thiourea derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders

Also Published As

Publication number Publication date
ZA951342B (en) 1996-08-19
CN1141041A (en) 1997-01-22
MX9603510A (en) 1997-03-29
WO1995022541A1 (en) 1995-08-24
AU1578895A (en) 1995-09-04
NZ279228A (en) 1997-11-24
TW418203B (en) 2001-01-11
EP0745078A1 (en) 1996-12-04
AU688852B2 (en) 1998-03-19
JPH09508915A (en) 1997-09-09
IL112689A0 (en) 1995-05-26

Similar Documents

Publication Publication Date Title
DE69530493D1 (en) Ablationsgerät
DE69531947D1 (en) Ausbreitbare ringprothese
DE69512030D1 (en) Cerebral-dilator
EP0696731A3 (en) Cytoanalyzer
DE59503739D1 (en) Polymer-sensor
DE69529159D1 (en) Hüftgelenkprothese
DE69502271D1 (en) Afterabtrennung
DE69511086D1 (en) Pyrimidinderivate
DE69504528D1 (en) Quenchkühler
DE69429543D1 (en) Koagulationszange
DE59503634D1 (en) Friercontainer
EP0701109A3 (en) Watermeter
DE69512382D1 (en) Deodorierte thermoplaste
DE59509661D1 (en) Heterocyclylbenzonitrile
DE69517588D1 (en) Gekühlter transportcontainer
DE69517886D1 (en) Spiropyranverbindung
ZA951343B (en) Enantiomerically pure (+)-liarozole
AU122938S (en) Breadbox
DE69508761D1 (en) Haloalkylierungsverfahren
SG47122A1 (en) Enantiomerically pure(-)-liarozole
DE59508136D1 (en) Phenylthio-oxazolin-derivate
DE69527047D1 (en) Bisazoverbindung
DE69506730D1 (en) Differentialer antriebsmechanismus
DE59503452D1 (en) Piezoresistiver widerstand
DE59510739D1 (en) N-cyanoaryl-stickstoffheterocyclen